Cancer-killing virus boosts immunotherapy in hard-to-treat cancer 15 Jun 2019 Combining a cancer-killing virus with immunotherapy could effectively treat advanced cancers that affect the limbs, a new study reveals. Find out more Show/Hide
Viruses show new promise in treating cancer 13 Sep 2018 Viruses have shown renewed promise in the treatment for cancer, after new research has shown they retain their cancer-killing ability even when injected into the bloodstream. Find out more Show/Hide
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma 30 Sep 2016 The Institute of Cancer Research, London, has issued the following statement from Professor Kevin Harrington in response to the decision by NICE to approve the use of talimogene laherparepvec (T-VEC) for treating inoperable metastatic melanoma in adults when systemically administered immunotherapies are not suitable. Find out more Show/Hide
World first as viral immunotherapy for skin cancer shows patient benefit in Phase III trial 26 May 2015